The University of Virginia School of Medicine is the graduate medical school of the University of Virginia. The school's facilities are on the University of Virginia grounds adjacent to Academical Village in Charlottesville, Virginia.

During the past decade, University of Virginia School of Medicine conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia School of Medicine" #1 sponsor was "University of Virginia" with 6 trials, followed by "Ancora Heart, Inc." with 3 trials sponsored, "Complexa, Inc." with 2 trials sponsored, "Quark Pharmaceuticals" with 2 trials sponsored and "AMAG Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia School of Medicine" #1 collaborator was "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)" with 2 trials as a collaborator, "Innovative Analytics" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "University of Wisconsin, Madison" with 2 trials as a collaborator and "Cardiovascular Clinical Science Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia School of Medicine" are "Heart Failure" (3 trials), "Acute Renal Failure" (2 trials), "Cardiomyopathy, Dilated" (2 trials), "Common Cold" (2 trials) and "PAH" (2 trials). Many other conditions were trialed in "University of Virginia School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Virginia School of Medicine" are "Drug" (15 trials), "Device" (5 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "150mg CXA-10" (1 trials), "3804-250A" (1 trials), "3804-291" (1 trials) and "75mg CXA-10" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia School of Medicine" are 25 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Virginia School of Medicine". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Virginia School of Medicine, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia School of Medicine, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".